Previous 10 | Next 10 |
JACKSON CENTER, PA / ACCESSWIRE / January 14, 2021 / Halberd Corp. (OTC PINK: HALB ) announced the filing of a provisional patent application on a proprietary combination of nutritional supplements (melatonin, zinc and Vitamin D) combined with low dose Naltrexone designed to reduce the sever...
JACKSON CENTER, PA / ACCESSWIRE / January 12, 2021 / Halberd Corp. (OTC PINK: HALB ) was recently included alongside Novavax Inc and Moderna Inc in a recent Wall Street PR article on Covid-19 related stocks poised to have an impact in 2021. Halberd was noted to be working in a different ...
Both Senate seats went to Democrats and this allows for a blue agenda with cannabis legalization being one of the top priorities. Arizona's legalization of recreational cannabis is already being geared up for with companies retooling in preparation. The industry will see continued...
JACKSON CENTER, PA / ACCESSWIRE / January 4, 2021 / Greetings From The CEO And Staff At HALBERD CORPORATION ! (OTC PINK: HALB ). First of all I want to wish all of our shareholders and constituents a Very Healthy, Happy and Prosperous New Year! A LOOK BACK I have been working sin...
2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...
Halberd's ([[HALB]] +8.2%) research has produced a second monoclonal antibody (mAb) against the Covid-19 spike protein after initial testing displayed a stronger affinity for the SARS-CoV-2 antigen than Halberd's initial antibody.Testing will continue on each antibody to establish potenc...
JACKSON CENTER, PA / ACCESSWIRE / December 23, 2020 / Halberd Corp. (OTC PINK: HALB ) research has produced a second monoclonal antibody (mAb) against the Covid-19 spike protein. Initial testing displays a stronger affinity for the SARS-CoV-2 antigen than Halberd's initial antibody. Testing ...
JACKSON CENTER, PA / ACCESSWIRE / December 17, 2020 / Halberd Corp. (OTC PINK: HALB ) announced they are pursuing development of their latest treatment variation in the fight against COVID-19. Halberd's provisional patent application, " Method For Treating And Curing Covid-19 Infection By Ut...
JACKSON CENTER, PA / ACCESSWIRE / December 14, 2020 / Halberd Corporation (OTC PINK: HALB ) announced its proprietary, highly potent, neutralizing antibody against SARS-CoV-2, which demonstrated very strong receptor specificity and inhibition of SARS-CoV-2 replication. Halberd's anti-Spike p...
Phoenix, Arizona--(Newsfile Corp. - December 10, 2020) - The Stock Day Podcast welcomed Halberd Corporation (OTC Pink: HALB) ("the Company"), a company with a patented extracorporeal treatment applicable to many hard-to-cure blood-borne and neurological diseases, including COVID-19, other viru...
News, Short Squeeze, Breakout and More Instantly...
Tykhe Corp Company Name:
HALB Stock Symbol:
OTCMKTS Market:
Walt Disney once said, "All our dreams can come true if we have the courage to pursue them". JACKSON CENTER, PA / ACCESSWIRE / May 22, 2024 / Halberd Corporation (OTC PINK:HALB) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues ...
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. JACKSON CENTER, PA / ACCESSWIRE / May 9, 2024 / Halberd Corporation's (OTC PINK:HALB) two active programs for the treatment and mitigation of the negative ...
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited participants but is currently expected to...